[Except fertility, place of myomectomy in perimenopause and after menopause]

J Gynecol Obstet Biol Reprod (Paris). 2011 Dec;40(8):902-17. doi: 10.1016/j.jgyn.2011.09.024. Epub 2011 Nov 5.
[Article in French]

Abstract

More and more perimenopausal and menopausal women seek an alternative to hysterectomy because they desire future pregnancy or wish to retain their uteri even if they have completed childbearing. Myomectomy may be an option. We can't know the evolution of leiomyomas. Hysteroscopic myomectomy is the treatment of submucous fibromas. Recurrence and subsequent surgery occurs in 16 to 21 % of cases. Intramural and subserousal myomas can be treated by myomectomy. Myomectomy should be performed laparoscopically because of shorter hospital stay, faster recovery and reduced postoperative pain. Second surgery is needed in 4-16 % of patients. If hysterectomy is performed, it should be by vaginal or laparoscopic route. There is no difference in perioperative morbidity between hysterectomy and myomectomy. Intra- and postoperative complications are similar between myomectomy and hysterectomy. Hysterectomy may be prefered if there is risk factor of malignancy or if the fibroma is discovered or has a rapid growth after menopause.

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Disease Progression
  • Female
  • Fertility / physiology
  • Gynecologic Surgical Procedures / adverse effects
  • Gynecologic Surgical Procedures / methods
  • Gynecologic Surgical Procedures / statistics & numerical data*
  • Humans
  • Leiomyoma / epidemiology
  • Leiomyoma / pathology
  • Leiomyoma / surgery*
  • Perimenopause* / physiology
  • Postmenopause* / physiology
  • Postoperative Complications / epidemiology
  • Pregnancy
  • Uterine Neoplasms / epidemiology
  • Uterine Neoplasms / pathology
  • Uterine Neoplasms / surgery*
  • Watchful Waiting / statistics & numerical data